Q1 2025 saw a 9.94% revenue decline and a net loss due to lower caffeine prices and higher R&D costs. Cash flow improved, and a major acquisition is under regulatory review, with approval timing uncertain.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.